CoreCap Advisors’s abrdn Healthcare Opportunities Fund THQ Stock Holding History

CoreCap Advisors’s Portfolio THQ Stock Details THQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$261K	Buy	14,184 +3,097	+28%	+$59.2K	0.01%	759
2026 Q2	$208K	Buy	+11,087	New	+$202K	0.01%	851
2026 Q1	–	Sell	-12,667	Closed	-$242K	–	3061
2025 Q4	$242K	Buy	12,667 +11,917	+1,589%	+$219K	0.01%	728
2025 Q3	$13K	Buy	+750	New	+$12.8K	﹤0.01%	1828
2025 Q2	–	Sell	-4,300	Closed	-$88.8K	–	3224
2025 Q1	$88.8K	Buy	4,300 +3,300	+330%	+$67.4K	﹤0.01%	948
2024 Q4	$18.9K	Sell	1,000 -1,800	-64%	-$37.2K	﹤0.01%	1556
2024 Q3	$61.8K	Buy	+2,800	New	+$59.9K	﹤0.01%	1110
2022 Q4	$4.95K	Buy	+250	New	+$4.93K	﹤0.01%	1748
2022 Q3	–	Sell	-250	Closed	-$5K	–	1934
2022 Q2	$5K	Buy	+250	New	+$5.23K	﹤0.01%	1691
2022 Q1	–	Sell	-250	Closed	-$6K	–	1936
2021 Q4	$6K	Buy	+250	New	+$6.01K	﹤0.01%	1720

Other funds holding THQ

AAG

Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

CoreCap Advisors's THQ Position: Q3 2026 in Review

CoreCap Advisors increased its abrdn Healthcare Opportunities Fund (THQ) stake by 28% in Q3 2026, buying an estimated $59.2K and bringing the position to 14,184 shares worth $261K. The position accounts for 0.01% of the portfolio, ranked #759.

CoreCap Advisors first reported a position in THQ in Q4 2021 and has held it in 10 quarters since. 2 funds tracked by Wall St. Rank hold THQ as of Q3 2026.

CoreCap Advisors held 14,184 shares of abrdn Healthcare Opportunities Fund worth $261K as of Q3 2026.
CoreCap Advisors bought 3,097 abrdn Healthcare Opportunities Fund shares in Q3 2026, an estimated $59.2K.
abrdn Healthcare Opportunities Fund made up 0.01% of CoreCap Advisors's portfolio in Q3 2026, its #759 holding.
CoreCap Advisors first reported a position in abrdn Healthcare Opportunities Fund in Q4 2021 and has held it in 10 quarters since.
2 funds tracked by Wall St. Rank held abrdn Healthcare Opportunities Fund as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.